Equities

Reckitt Benckiser Group PLC

RKT:LSE

Reckitt Benckiser Group PLC

Consumer Staples Personal Care, Drug and Grocery Stores
  • Price (GBX)4,786.00
  • Today's Change45.00 / 0.95%
  • Shares traded193.74k
  • 1 Year change-12.02%
  • Beta0.1055
Data delayed at least 20 minutes, as of Nov 22 2024 09:43 GMT.
More ▼

Forecasts data is unavailable for this security.

Consensus recommendation

  • 14-Dec-23
  • 19-Sep-24
  • 17-Oct-24
  • 14-Nov-24
Select bar for recommendation details.
Recommendations14-Nov-24
Buy4
Outperform6
Hold9
Sell1
Strong Sell0

Share price forecast

The 17 analysts offering 12 month price targets for Reckitt Benckiser Group Plc have a median target of 5,600.00, with a high estimate of 7,170.00 and a low estimate of 4,400.00. The median estimate represents a 18.12% increase from the last price of 4,741.00.
High51.2%7,170.00
Med18.1%5,600.00
Low-7.2%4,400.00

Dividends

In 2023, Reckitt Benckiser Group PLC reported a dividend of 1.93 GBP, which represents a 5.02% increase over last year. The 18 analysts covering the company expect dividends of 2.00 GBP for the upcoming fiscal year, an increase of 3.95%.
Div growth (TTM)5.02%
More ▼

Earnings history & estimates

Reckitt Benckiser Group Plc reported annual 2023 earnings of 323.40 per share on Feb 28, 2024.
Average growth rate-1.25%
More ▼

Revenue history & estimates

of 3.46bn. This bettered the 3.21bn consensus of the 4 analysts covering the company.
Average growth rate+2.90%
Reckitt Benckiser Group plc had revenues for the full year 2023 of 14.61bn. This was 1.07% above the prior year's results.
Average growth rate+3.45%
More ▼
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.